Flexion Therapeutics Stock EBITDA
Flexion Therapeutics fundamentals help investors to digest information that contributes to Flexion Therapeutics' financial success or failures. It also enables traders to predict the movement of Flexion Stock. The fundamental analysis module provides a way to measure Flexion Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Flexion Therapeutics stock.
Flexion |
Flexion Therapeutics Company EBITDA Analysis
Flexion Therapeutics' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Flexion Therapeutics EBITDA | (71.2 M) |
Most of Flexion Therapeutics' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Flexion Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Flexion Therapeutics reported earnings before interest,tax, depreciation and amortization of (71.2 Million). This is 108.11% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The ebitda for all United States stocks is 101.83% higher than that of the company.
Flexion EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Flexion Therapeutics' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Flexion Therapeutics could also be used in its relative valuation, which is a method of valuing Flexion Therapeutics by comparing valuation metrics of similar companies.Flexion Therapeutics is currently under evaluation in ebitda category among related companies.
Flexion Fundamentals
| Return On Asset | -18.99 | |||
| Profit Margin | (92.52) % | |||
| Operating Margin | (71.24) % | |||
| Current Valuation | 408.79 M | |||
| Shares Outstanding | 49.94 M | |||
| Shares Owned By Insiders | 3.58 % | |||
| Shares Owned By Institutions | 92.20 % | |||
| Number Of Shares Shorted | 5.67 M | |||
| Price To Earning | (8.29) X | |||
| Price To Book | 35.88 X | |||
| Price To Sales | 4.43 X | |||
| Revenue | 102.74 M | |||
| Gross Profit | 66.53 M | |||
| EBITDA | (71.2 M) | |||
| Net Income | (95.05 M) | |||
| Cash And Equivalents | 131.43 M | |||
| Cash Per Share | 2.61 X | |||
| Total Debt | 228.9 M | |||
| Current Ratio | 4.61 X | |||
| Book Value Per Share | (0.78) X | |||
| Cash Flow From Operations | (59.19 M) | |||
| Short Ratio | 3.74 X | |||
| Earnings Per Share | (2.20) X | |||
| Price To Earnings To Growth | (0.19) X | |||
| Number Of Employees | 257 | |||
| Beta | 1.34 | |||
| Market Capitalization | 455.47 M | |||
| Total Asset | 127.14 M | |||
| Retained Earnings | (686.19 M) | |||
| Working Capital | 104.04 M | |||
| Current Asset | 112.1 M | |||
| Current Liabilities | 8.06 M | |||
| Z Score | -6.4 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Flexion Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Flexion Therapeutics' short interest history, or implied volatility extrapolated from Flexion Therapeutics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Flexion Stock
If you are still planning to invest in Flexion Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Flexion Therapeutics' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |